tiprankstipranks
Trending News
More News >
Eastman Kodak Company (KODK)
NYSE:KODK
Advertisement

Kodak (KODK) AI Stock Analysis

Compare
1,344 Followers

Top Page

KODK

Kodak

(NYSE:KODK)

Rating:44Neutral
Price Target:
$5.50
▼(-10.28% Downside)
Kodak's overall stock score is low due to significant financial challenges, including declining revenue, profitability issues, and negative cash flows. Technical analysis indicates bearish momentum, and valuation metrics are unattractive. The earnings call further highlighted financial difficulties and concerns about the company's future viability.

Kodak (KODK) vs. SPDR S&P 500 ETF (SPY)

Kodak Business Overview & Revenue Model

Company DescriptionEastman Kodak Company provides hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, and entertainment markets worldwide. The company operates through Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment offers digital offset plate and computer-to-plate imaging solutions to commercial industries, including commercial print, direct mail, book publishing, newspapers and magazines, and packaging. The Digital Printing segment provides electrophotographic printing solutions, such as The ASCEND and NEXFINITY printers; prosper products, including the PROSPER 6000 Press, PROSPER Writing Systems, PROSPER press systems, and PROSPER components; versamark products; and PRINERGY workflow production software. The Advanced Materials and Chemicals segment engages in industrial film and chemicals, motion picture, and advanced materials and functional printing businesses. This segment also comprises the Kodak Research Laboratories, which conducts research, develops new product or new business opportunities, and files patent applications for its inventions and innovations, as well as manages licensing of its intellectual property to third parties. The Brand segment engages in the licensing of Kodak brand to third parties. The company engages in the operation of Eastman Business Park, a technology center and industrial complex. It sells its products and services through direct sales, third party resellers, dealers, channel partners, and distributors. Eastman Kodak Company was founded in 1880 and is headquartered in Rochester, New York.
How the Company Makes MoneyKodak generates revenue through multiple key streams. The Digital Printing segment contributes significantly by providing commercial printing solutions, including inkjet technology and workflow software, catering to businesses in need of high-quality printing services. The Traditional Printing segment, which includes film and paper products, still contributes to revenue but has seen a decline due to the shift toward digital solutions. Additionally, Kodak's Advanced Materials and Chemicals segment offers specialized materials used in various applications, including electronics and 3D printing, further diversifying its income. The company has formed strategic partnerships with other technology firms and service providers to enhance its product offerings and market reach, allowing it to leverage synergies and increase its revenue potential.

Kodak Earnings Call Summary

Earnings Call Date:Aug 11, 2025
(Q2-2025)
|
% Change Since: -9.59%|
Next Earnings Date:Nov 11, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture for Kodak. While there were positive developments, such as growth in the AMC business and progress in pharmaceutical manufacturing, financial metrics like revenue, gross profit, and net income showed declines. Additionally, concerns about the company's ability to continue as a going concern added a negative aspect to the sentiment.
Q2-2025 Updates
Positive Updates
Advanced Materials and Chemicals (AMC) Growth
The AMC business showed continued revenue growth, demonstrating successful investments in this area.
U.S. Manufacturing Commitment
Kodak reinforced its commitment to U.S. manufacturing, with several products like motion picture film, digital printers, ink, and chemicals made domestically.
Pharmaceutical Manufacturing Initiative
Kodak's cGMP pharmaceutical manufacturing facility is now FDA registered and certified to manufacture and sell regulated pharmaceutical products.
Series C Preferred Stock Exchange
The Series C preferred stock was exchanged for common stock, eliminating $100 million in preferred stock and over $24 million in accrued dividends.
Pension Plan Termination Process
The KRIP termination is proceeding as planned, with an estimated $500 million to revert to the company, aiding in debt reduction.
Negative Updates
Revenue Decline
Revenue for Q2 2025 was $263 million, a slight decline from $267 million in Q2 2024, reflecting a 1% decrease year-over-year.
Gross Profit Decline
Gross profit percentage decreased from 22% in Q2 2024 to 19% in Q2 2025, impacted by lower volumes and higher costs.
Net Loss for the Quarter
Kodak reported a net loss of $26 million for Q2 2025 compared to a net income of $26 million in the prior year quarter.
Operational EBITDA Decline
Operational EBITDA for Q2 2025 was $9 million, down from $12 million in the prior year quarter, impacted by lower volumes and costs.
Going Concern Doubts
There is substantial doubt about Kodak's ability to continue as a going concern due to upcoming maturities of debt and preferred stock.
Company Guidance
During the Eastman Kodak Q2 2025 Earnings Conference Call, guidance focused on several key metrics and initiatives. Kodak reported a revenue of $263 million for the second quarter of 2025, compared to $267 million in the same period in 2024, marking a slight decline. The company's gross profit percentage stood at 19%, down from 22% in the previous year, attributed to lower volumes and increased manufacturing costs. A significant focus was on deleveraging, with plans to use approximately $500 million in reverted pension assets to reduce long-term debt. Operational EBITDA decreased to $9 million from $12 million year-over-year, impacted by higher aluminum costs and lower volumes. The company highlighted growth in its Advanced Materials and Chemicals (AMC) segment, with a newly registered cGMP pharmaceutical manufacturing facility in Rochester, New York. Additionally, Kodak discussed the conversion of Series C preferred stock to common stock, representing about 15.7% of outstanding shares post-exchange. Despite challenges, Kodak emphasized its commitment to U.S. manufacturing and its strategic investments in innovation and operational efficiency.

Kodak Financial Statement Overview

Summary
Kodak's financial performance shows mixed results with significant challenges. The income statement reflects declining revenue and profitability pressures, particularly in operational efficiency. The balance sheet shows moderate stability but highlights concerns over declining equity. Cash flow analysis underscores significant liquidity and cash generation issues. While there are areas of stability, the overall financial health is impacted by operational inefficiencies and cash flow challenges.
Income Statement
45
Neutral
Kodak's income statement reveals moderate challenges and mixed performance. The TTM shows a slight decrease in total revenue compared to the previous year, indicating a revenue growth rate of -0.19%. Gross Profit Margin remains stable at approximately 19.22% TTM, but the Net Profit Margin declined to 6.05% TTM. EBIT and EBITDA margins are weak, with EBIT Margin negative at -2.5% TTM, signaling operational inefficiencies. Kodak faces significant profitability challenges, although the Gross Profit Margin stability is a positive aspect.
Balance Sheet
50
Neutral
Kodak's balance sheet is characterized by moderate stability with some concerns. The Debt-to-Equity Ratio is 0.65 TTM, which is reasonable, but the decreasing Stockholders' Equity raises concerns. The Equity Ratio is 40.42% TTM, indicating a fair level of asset financing through equity. Return on Equity (ROE) is 8.04% TTM, showing moderate effectiveness in generating returns from equity. A steady equity ratio is a strength, but declining equity suggests potential risk.
Cash Flow
40
Negative
Kodak's cash flow position is concerning, highlighted by negative Free Cash Flow of -$81 million TTM. The Operating Cash Flow to Net Income Ratio is -0.98 TTM, reflecting cash flow challenges despite reported net income. The Free Cash Flow to Net Income Ratio is -1.29 TTM, indicating cash flow issues relative to profitability. Although the company has managed to maintain some financing flexibility, negative cash flow metrics pose significant risks.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.04B1.04B1.12B1.21B1.15B1.03B
Gross Profit193.00M203.00M210.00M170.00M164.00M135.00M
EBITDA106.00M197.00M169.00M100.00M92.00M-327.00M
Net Income11.00M102.00M75.00M26.00M24.00M-544.00M
Balance Sheet
Total Assets1.93B2.00B2.35B2.29B2.17B1.25B
Cash, Cash Equivalents and Short-Term Investments155.00M201.00M255.00M217.00M362.00M196.00M
Total Debt479.00M499.00M495.00M363.00M312.00M80.00M
Total Liabilities1.18B1.14B1.21B1.04B1.19B980.00M
Stockholders Equity750.00M859.00M1.14B1.24B977.00M268.00M
Cash Flow
Free Cash Flow-45.00M-63.00M6.00M-147.00M-68.00M-52.00M
Operating Cash Flow-47.00M-7.00M38.00M-116.00M-47.00M-35.00M
Investing Cash Flow-56.00M-39.00M-32.00M-56.00M-20.00M-13.00M
Financing Cash Flow-7.00M-23.00M85.00M43.00M238.00M10.00M

Kodak Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.13
Price Trends
50DMA
6.31
Negative
100DMA
6.19
Negative
200DMA
6.43
Negative
Market Momentum
MACD
-0.16
Positive
RSI
47.51
Neutral
STOCH
53.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KODK, the sentiment is Negative. The current price of 6.13 is below the 20-day moving average (MA) of 6.38, below the 50-day MA of 6.31, and below the 200-day MA of 6.43, indicating a bearish trend. The MACD of -0.16 indicates Positive momentum. The RSI at 47.51 is Neutral, neither overbought nor oversold. The STOCH value of 53.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KODK.

Kodak Risk Analysis

Kodak disclosed 45 risk factors in its most recent earnings report. Kodak reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Kodak Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$1.93B67.4022.58%4.19%48.69%
64
Neutral
$10.71B16.037.42%2.02%2.57%-16.39%
61
Neutral
$560.82M22.819.03%2.83%-3.57%-6.69%
58
Neutral
$310.41M-17.22%4.20%-6.94%74.52%
58
Neutral
$56.95M13.93
50
Neutral
$314.41M7.73-1.17%62.44%-109.84%
44
Neutral
$490.14M14.121.14%-2.17%-112.27%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
KODK
Kodak
6.13
0.82
15.44%
ACTG
Acacia Research
3.34
-1.43
-29.98%
CASS
Cass Information Systems
43.45
1.49
3.55%
QUAD
Quad/Graphics
6.54
1.99
43.74%
LZ
LegalZoom
10.98
4.43
67.63%
YSXT
YSX Tech Co., Ltd Class A
2.50
-1.53
-37.97%

Kodak Corporate Events

Executive/Board ChangesShareholder Meetings
Kodak Shareholders Approve Leadership and Financial Oversight
Positive
May 27, 2025

On May 21, 2025, Eastman Kodak Company held its Annual Meeting of Shareholders virtually, with a quorum present for voting. Shareholders elected the company’s nominees for director, approved executive compensation, and ratified Ernst & Young LLP as the independent accounting firm, indicating continued shareholder support for the company’s leadership and financial oversight.

Private Placements and Financing
Kodak Enters $100 Million Sales Agreement with BofA
Neutral
May 21, 2025

On May 21, 2025, Eastman Kodak Company entered into a Sales Agreement with BofA Securities, Inc. to offer and sell up to $100 million of its common stock through at-the-market offerings. The proceeds from these sales are intended for general corporate purposes, with sales made at prevailing market prices. The agreement does not obligate Kodak or BofA to sell or buy shares, and Kodak has agreed to indemnify BofA against certain liabilities.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025